FSTL3 and colorectal carcinoma: The results implied that higher FSTL3 mRNA expression was notably correlated with OS, disease-free survival (DFS), progression free survival, as well as disease-specific survival in CRC patients utilizing data from TCGA cohort (Figures 6H–K).